It can therefore be used as a predictor of favorable response to oral iron treatment in patients with IBD [46] and enables clinicians to design optimal oral iron dosing and timing schedules that exploit conditions minimizing the iron-triggered induction of hepcidin [47]. Here, HAMP is linked to inflammatory bowel disease.